Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
European Journal of Gastroenterology & Hepatology|January 14, 2016
Identifying predictors of low adherence in patients with inflammatory bowel diseaseSofie Coenen, Ellen Weyts, Vera Ballet, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's DiseaseMagali de Bruyn, Ingrid Arijs, Gert De Hertogh, et al.
Clinical and Translational Gastroenterology|December 9, 2016
Rapid Test for Infliximab Drug Concentration Allows Immediate Dose AdaptationThomas Van Stappen, Lize Bollen, Niels Vande Casteele, et al.
Inflammatory Bowel Diseases|October 25, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral CenterMichiel Bronswijk, Annick Moens, Matthias Lenfant, et al.
Inflammatory Bowel Diseases|December 9, 2016
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist TherapyBruce E Sands, William J Sandborn, Gert Van Assche, et al.
Journal of Crohn'S & Colitis|August 15, 2012
Intersphincteric proctectomy with end-colostomy for anorectal Crohn's disease results in early and severe proximal colonic recurrenceAnthony de Buck van Overstraeten, Albert M Wolthuis, Séverine Vermeire, et al.
Inflammatory Bowel Diseases|January 9, 2007
Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization?Chong Shen, Gert de Hertogh, Dominique M A Bullens, et al.
Digestion|January 17, 2020
Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An UpdateEmanuel Burri, Michel H Maillard, Alain M Schoepfer, et al.
European Journal of Gastroenterology & Hepatology|February 21, 2018
The operative risk and natural history after the diagnosis of ileal penetrating Crohn's diseasePeter Bossuyt, Celine Debeuckelaere, Marc Ferrante, et al.
Inflammatory Bowel Diseases|June 1, 2004
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitisJoris Arts, Geert D'Haens, Miranda Zeegers, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
European Journal of Gastroenterology & Hepatology|January 14, 2016
Identifying predictors of low adherence in patients with inflammatory bowel diseaseSofie Coenen, Ellen Weyts, Vera Ballet, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's DiseaseMagali de Bruyn, Ingrid Arijs, Gert De Hertogh, et al.
Clinical and Translational Gastroenterology|December 9, 2016
Rapid Test for Infliximab Drug Concentration Allows Immediate Dose AdaptationThomas Van Stappen, Lize Bollen, Niels Vande Casteele, et al.
Inflammatory Bowel Diseases|October 25, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral CenterMichiel Bronswijk, Annick Moens, Matthias Lenfant, et al.
Inflammatory Bowel Diseases|December 9, 2016
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist TherapyBruce E Sands, William J Sandborn, Gert Van Assche, et al.
Journal of Crohn'S & Colitis|August 15, 2012
Intersphincteric proctectomy with end-colostomy for anorectal Crohn's disease results in early and severe proximal colonic recurrenceAnthony de Buck van Overstraeten, Albert M Wolthuis, Séverine Vermeire, et al.
Inflammatory Bowel Diseases|January 9, 2007
Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization?Chong Shen, Gert de Hertogh, Dominique M A Bullens, et al.
Digestion|January 17, 2020
Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An UpdateEmanuel Burri, Michel H Maillard, Alain M Schoepfer, et al.
European Journal of Gastroenterology & Hepatology|February 21, 2018
The operative risk and natural history after the diagnosis of ileal penetrating Crohn's diseasePeter Bossuyt, Celine Debeuckelaere, Marc Ferrante, et al.
Inflammatory Bowel Diseases|June 1, 2004
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitisJoris Arts, Geert D'Haens, Miranda Zeegers, et al.
Pageof 29